日本新薬(株)□企業情報

主市場業種証券コード/EDINET英名称
東証PRM医薬品4516/E00931-

日証金(2024-05-13付)

信用売り残高
400株
前日比
300%
信用買い残高
4万1300株
前日比
66.53%

□もっと見る

東証(2024-05-02付)

信用売り残高
2万5700株
前週比
-4.81%
信用買い残高
35万2200株
前週比
-2.71%

□もっと見る

日証協(2024-05-02付)

貸付残高
88万9013株
前週比
1.44%
貸付新規
57万1751株
前週比
98.04%

□もっと見る

逆日歩(品貸料)

2023-10-19
2023-10-04
2023-08-31
2023-08-30

□もっと見る

機関の空売り残高情報

計算日空売り者残高割合増減率残高数量増減量備考
2023/08/31Integrated Core Strategies0.030%-1.620%22,700株-1,138,760報告義務消失
2023/08/30Integrated Core Strategies1.650%+0.060%1,161,460株+43,000
2023/08/29Integrated Core Strategies1.590%+0.110%1,118,460株+78,100
2023/08/28Integrated Core Strategies1.480%+0.130%1,040,360株+90,400
2023/08/25Integrated Core Strategies1.350%+0.140%949,960株+98,000
2023/08/21Integrated Core Strategies1.210%+0.100%851,960株+70,500
2023/08/16Integrated Core Strategies1.110%+0.100%781,460株+68,200
2023/08/09Integrated Core Strategies1.010%+0.110%713,260株+76,400
2023/08/04Integrated Core Strategies0.900%+0.080%636,860株+60,500
2023/07/28Integrated Core Strategies0.820%+0.120%576,360株+81,875
2023/07/24Integrated Core Strategies0.700%+0.090%494,485株+63,900
2023/07/18Integrated Core Strategies0.610%+0.110%430,585株+77,900
2023/07/11Integrated Core Strategies0.500%0%352,685株

Page Top